A 24 h corticosterone exposure exacerbates excitotoxic insult in rat hippocampal slice cultures independently of glucocorticoid receptor activation or protein synthesis

Brain Research

Volumn 1082, Issue 1, 2006, Pages 165-172

  Mulholland, Patrick J ^a   Self, Rachel L ^a   Hensley, Allison K ^a   Little, Hilary J ^b   Littleton, John M ^c   Prendergast, Mark A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c University of Kentucky   (United States)

Author keywords

Excitotoxicity; Glucocorticoid; Hippocampus; Propidium iodide; Protein synthesis

Indexed keywords

CORTICOSTERONE; CYCLOHEXIMIDE; DIZOCILPINE; GLUCOCORTICOID ANTAGONIST; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PROPIDIUM IODIDE; PROTEIN SYNTHESIS INHIBITOR; SPIRONOLACTONE; AMINO ACID RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT; DIZOCILPINE MALEATE; ENZYME INHIBITOR; N METHYLASPARTIC ACID; NEUROTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CYTOTOXICITY; EVALUATION; EXCITOTOXICITY; EXPOSURE; FEMALE; FLUORESCENCE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; RECEPTOR UPREGULATION; TISSUE CULTURE; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; NEWBORN; PHYSIOLOGY;

ANIMALIA;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CORTICOSTERONE; DIZOCILPINE MALEATE; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; NEUROTOXINS; PROPIDIUM; PROTEIN BIOSYNTHESIS; RATS; RECEPTORS, GLUCOCORTICOID;

EID: 33645863759     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.01.069     Document Type: Article

References (70)

1. Abraham I., Harkany T., Horvath K.M., Veenema A.H., Penke B., Nyakas C., and Luiten P.G. Chronic corticosterone administration dose-dependently modulates Abeta(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J. Neuroendocrinol. 12 (2000) 486-494
2. Adinoff B., Ruether K., Krebaum S., Iranmanesh A., and Williams M.J. Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol.: Clin. Exp. Res. 27 (2003) 1420-1427
3. Armanini M.P., Hutchins C., Stein B.A., and Sapolsky R.M. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res. 532 (1990) 7-12
4. Bartanusz V., Aubry J.M., Pagliusi S., Jezova D., Baffi J., and Kiss J.Z. Stress-induced changes in messenger RNA levels of N-methyl-d-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience 66 (1995) 247-252
5. Brooke S., Chan R., Howard S., and Sapolsky R. Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9457-9462
6. Bruno V., Sureda F.X., Storto M., Casabona G., Caruso A., Knopfel T., Kuhn R., and Nicoletti F. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. J. Neurosci. 17 (1997) 1891-1897
7. Cato A.C., Konig H., Ponta H., and Herrlich P. Steroids and growth promoting factors in the regulation of expression of genes and gene networks. J. Steroid Biochem. Mol. Biol. 43 (1992) 63-68
8. Cato A.C., Ponta H., and Herrlich P. Regulation of gene expression by steroid hormones. Prog. Nucleic Acid Res. Mol. Biol. 43 (1992) 1-36
9. Chen Y.Z., and Qiu J. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid. Mol. Cell. Biol. Res. Commun. 2 (1999) 145-149
10. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
11. de Kloet E.R., Oitzl M.S., and Joels M. Functional implications of brain corticosteroid receptor diversity. Cell. Mol. Neurobiol. 13 (1993) 433-455
12. Diamond M.J., Miner J.N., Yoshinaga S.K., and Yamamoto K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 (1990) 1266-1272
13. Elliott E.M., and Sapolsky R.M. Corticosterone impairs hippocampal neuronal calcium regulation-Possible mediating mechanisms. Brain Res. 602 (1993) 84-90
14. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
15. Gould E., Woolley C.S., and McEwen B.S. Short-term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus. Neuroscience 37 (1990) 367-375
16. Hassan A.H., von Rosenstiel P., Patchev V.K., Holsboer F., and Almeida O.F. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp. Neurol. 140 (1996) 43-52
17. Horner H.C., Packan D.R., and Sapolsky R.M. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52 (1990) 57-64
18. Hoschl C., and Hajek T. Hippocampal damage mediated by corticosteroids-A neuropsychiatric research challenge. Eur. Arch. Psychiatry Clin. Neurosci. 251 (2001) II81-II88
19. Imai S., Okayama N., Shimizu M., and Itoh M. Increased intracellular calcium activates serum and glucocorticoid-inducible kinase 1 (SGK1) through a calmodulin-calcium calmodulin dependent kinase kinase pathway in Chinese hamster ovary cells. Life Sci. 72 (2003) 2199-2209
20. Institute of Laboratory Animal Resources. Commission on Life Sciences, National Research Council, Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
21. Joels M., and de Kloet E.R. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245 (1989) 1502-1505
22. Joels M., and de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43 (1994) 1-36
23. Karst H., and Joels M. The induction of corticosteroid actions on membrane properties of hippocampal CA1 neurons requires protein synthesis. Neurosci. Lett. 130 (1991) 27-31
24. Karst H., and Joels M. Effect of chronic stress on synaptic currents in rat hippocampal dentate gyrus neurons. J. Neurophysiol. 89 (2003) 625-633
25. Karst H., Wadman W.J., and Joels M. Corticosteroid receptor-dependent modulation of calcium currents in rat hippocampal CA1 neurons. Brain Res. 649 (1994) 234-242
26. Kerr D.S., Campbell L.W., Hao S.Y., and Landfield P.W. Corticosteroid modulation of hippocampal potentials: increased effect with aging. Science 245 (1989) 1505-1509
27. 2+ conductances: relevance to brain aging. Proc. Natl Acad. Sci. U. S. A. 89 (1992) 8527-8531
28. Kristensen B.W., Noer H., Gramsbergen J.B., Zimmer J., and Noraberg J. Colchicine induces apoptosis in organotypic hippocampal slice cultures. Brain Res. 964 (2003) 264-278
29. Krugers H.J., Koolhaas J.M., Bohus B., and Korf J. A single social stress-experience alters glutamate receptor-binding in rat hippocampal CA3 area. Neurosci. Lett. 154 (1993) 73-77
30. Lahtinen H., Autere A.M., Paalasmaa P., Lauri S.E., and Kaila K. Post-insult activity is a major cause of delayed neuronal death in organotypic hippocampal slices exposed to glutamate. Neuroscience 105 (2001) 131-137
31. Li H., Pin S., Zeng Z., Wang M.M., Andreasson K.A., and McCullough L.D. Sex differences in cell death. Ann. Neurol. 58 (2005) 317-321
32. Malkoski S.P., Handanos C.M., and Dorin R.I. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol. Cell. Endocrinol. 127 (1997) 189-199
33. Martens U., Capito B., and Wree A. Septotemporal distribution of [3H]MK-801, [3H]AMPA and [3H]Kainate binding sites in the rat hippocampus. Anat. Embryol. 198 (1998) 195-204
34. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 15 (1998) 171-179
35. McEwen B.S., de Kloet E.R., and Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66 (1986) 1121-1188
36. McIntosh L.J., and Sapolsky R.M. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp. Neurol. 141 (1996) 201-206
37. McIntosh L.J., and Sapolsky R.M. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology 17 (1996) 873-882
38. Mulholland P.J., and Prendergast M.A. Transection of intrinsic polysynaptic pathways reduces N-methyl-d-aspartate neurotoxicity in hippocampal slice cultures. Neurosci. Res. 46 (2003) 369-376
39. Mulholland P.J., Self R.L., Harris B.R., Littleton J.M., and Prendergast M.A. Choline exposure reduces potentiation of N-methyl-d-aspartate toxicity by corticosterone in the developing hippocampus. Brain Res. Dev. Brain Res. 153 (2004) 203-211
40. Mulholland P.J., Self R.L., Harris B.R., Littleton J.M., and Prendergast M.A. (-)-nicotine ameliorates corticosterone's potentiation of N-methyl-d-aspartate receptor-mediated cornu ammonis 1 toxicity. Neuroscience 125 (2004) 671-682
41. Pomara N., Greenberg W.M., Branford M.D., and Doraiswamy P.M. Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. Psychopharmacol. Bull. 37 (2003) 120-134
42. 2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J. Neurochem. 68 (1997) 1679-1685
43. Prendergast M.A., Harris B.R., Mayer S., Holley R.C., Hauser K.F., and Littleton J.M. Chronic nicotine exposure reduces N-methyl-d-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin-D28K overexpression. Neuroscience 102 (2001) 75-85
44. Prendergast M.A., Harris B.R., Mayer S., Holley R.C., Pauly J.R., and Littleton J.M. Nicotine exposure reduces N-methyl-d-aspartate toxicity in the hippocampus: relation to distribution of the alpha7 nicotinic acetylcholine receptor subunit. Med. Sci. Monit. 7 (2001) 1153-1160
45. Prendergast M.A., Harris B.R., Mulholland P.J., Blanchard II J.A., Gibson D.A., Holley R.C., and Littleton J.M. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-d-aspartate receptors. Neuroscience 124 (2004) 869-877
46. Qiu J., Wang P., Jing Q., Zhang W., Li X., Zhong Y., Sun G., Pei G., and Chen Y. Rapid activation of ERK1/2 mitogen-activated protein kinase by corticosterone in PC12 cells. Biochem. Biophys. Res. Commun. 287 (2001) 1017-1024
47. Reul J.M., and de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2511
48. Reul J.M., Pearce P.T., Funder J.W., and Krozowski Z.S. Type I and type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration. Mol. Endocrinol. 3 (1989) 1674-1680
49. Sakaguchi T., Okada M., Kuno M., and Kawasaki K. Dual mode of N-methyl-d-aspartate-induced neuronal death in hippocampal slice cultures in relation to N-methyl-d-aspartate receptor properties. Neuroscience 76 (1997) 411-423
50. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J. Neurosci. 5 (1985) 1228-1232
51. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus. Temporal aspects of synergy with kainic acid. Neuroendocrinology 43 (1986) 440-444
52. Sapolsky R.M. Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog. Brain Res. 86 (1990) 13-23
53. Sapolsky R.M., and Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229 (1985) 1397-1400
54. Sapolsky R.M., Packan D.R., and Vale W.W. Glucocorticoid toxicity in the hippocampus: in vitro demonstration. Brain Res. 453 (1988) 367-371
55. Sousa N., Paula-Barbosa M.M., and Almeida O.F. Ligand and subfield specificity of corticoid-induced neuronal loss in the rat hippocampal formation. Neuroscience 89 (1999) 1079-1087
56. Stein-Behrens B.A., Elliott E.M., Miller C.A., Schilling J.W., Newcombe R., and Sapolsky R.M. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus. J. Neurochem. 58 (1992) 1730-1735
57. Stein-Behrens B.A., Lin W.J., and Sapolsky R.M. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J. Neurochem. 63 (1994) 596-602
58. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 (1991) 173-182
59. Strohle A., and Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36 (2003) S207-S214
60. Supko D.E., and Johnston M.V. Dexamethasone potentiates NMDA receptor-mediated neuronal injury in the postnatal rat. Eur. J. Pharmac. 270 (1994) 105-113
61. 2+ elevation in cultured rat hippocampal neurons. J. Neurochem. 83 (2002) 1441-1451
62. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59 (1997) 365-393
63. Wehling M., Eisen C., and Christ M. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids. Mol. Cell. Endocrinol. 90 (1992) C5-C9
64. Weiland N.G., Orchinik M., and Tanapat P. Chronic corticosterone treatment induces parallel changes in N-methyl-d-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus. Neuroscience 78 (1997) 653-662
65. Wolbers F., Buijtenhuijs P., Haanen C., and Vermes I. Apoptotic cell death kinetics in vitro depend on the cell types and inducers used. Apoptosis 9 (2004) 385-392
66. Woolley C.S., Gould E., Sakai R.R., Spencer R.L., and McEwen B.S. Effects of aldosterone or RU28362 treatment on adrenalectomy-induced cell death in the dentate gyrus of the adult rat. Brain Res. 554 (1991) 312-315
67. Yusim A., Ajilore O., Bliss T., and Sapolsky R. Glucocorticoids exacerbate insult-induced declines in metabolism in selectively vulnerable hippocampal cell fields. Brain Res. 870 (2000) 109-117
68. Yusim A., Franklin L., Brooke S., Ajilore O., and Sapolsky R. Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants. J. Neurochem. 74 (2000) 1000-1007
69. Zhang X.K., Dong J.M., and Chiu J.F. Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. J. Biol. Chem. 266 (1991) 8245-8248
70. Zimmer J., Kristensen B.W., Jakobsen B., and Noraberg J. Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 19 (2000) 7-21